Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by country, state, or city

Search by locations

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “California”

BIVV020 (SAR445088) in Prevention and Treatment of Antibody-mediated Rejection (AMR)Active Not Recruiting
NCT05156710Phase 2Updated Aug 21, 2026
Sponsor: Sanofi
Transplant Rejection
United States, Canada, France, Germany, Italy +2 more
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)Recruiting
NCT05139017Phase 2, Phase 3Updated Aug 21, 2026
Sponsor: Merck Sharp & Dohme LLC
DLBCL · Diffuse Large B-Cell Lymphoma
United States, Argentina, Australia, Brazil, Canada +21 more
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b StudyRecruiting
NCT06937086Phase 3Updated Aug 21, 2026
Sponsor: Eli Lilly and Company
Ulcerative Colitis · Obesity or Overweight
United States, Austria, Belgium, Brazil, Bulgaria +18 more
A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzabrutinib Compared With Placebo in Participants 18 Years of Age and Older With Warm Autoimmune Hemolytic AnemiaRecruiting
NCT07086976Phase 3Updated Aug 21, 2026
Sponsor: Sanofi
Autoimmune Haemolytic Anaemia
United States, Argentina, Austria, Brazil, China +12 more
A Single-Dose Study of MT-201 and Concomitant Infliximab in Healthy ParticipantsRecruiting
NCT07776782Phase 1Updated Aug 21, 2026
Sponsor: Mirador Therapeutics, Inc.
Healthy Volunteer
United States
An Extension Study of Ublituximab in Participants With Relapsing Multiple SclerosisActive Not Recruiting
NCT04130997Phase 3Updated Aug 21, 2026
Sponsor: TG Therapeutics, Inc.
Relapsing Multiple Sclerosis (RMS)
United States, Belarus, Croatia, Georgia, Poland +3 more
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate CancerRecruiting
NCT07213674Phase 3Updated Aug 21, 2026
Sponsor: Amgen
Metastatic Castration-resistant Prostate Cancer
United States, Australia, Austria, Belgium, Canada +13 more
A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use DisorderRecruiting
NCT07219966Phase 3Updated Aug 21, 2026
Sponsor: Eli Lilly and Company
Alcohol Use Disorder
United States, Belgium, China, Germany, Japan +3 more
Syk Inhibition in MItigating Lung Allograft Rejection (SIMILAR): A Trial to Evaluate the Safety and Tolerability of Fostamatinib in Lung Transplant Patients With Donor-Specific AntibodiesRecruiting
NCT06948097Phase 1Updated Aug 21, 2026
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Lung Transplantation
United States
A Pilot Study of Anselamimab in Patients With AL Amyloidoma and Measurable Tissue InvolvementNot Yet Recruiting
NCT07615270EARLY_Phase 1Updated Aug 21, 2026
Sponsor: Stanford University
AL Amyloidosis
United States
8-Chloroadenosine in Combination With Venetoclax for the Treatment of Patients With Relapsed/Refractory Acute Myeloid LeukemiaRecruiting
NCT05263284Phase 1Updated Aug 21, 2026
Sponsor: City of Hope Medical Center
Acute Myeloid Leukemia · Recurrent Acute Myeloid Leukemia · Refractory Acute Myeloid Leukemia
United States
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)Recruiting
NCT05554393Phase 2Updated Aug 21, 2026
Sponsor: National Cancer Institute (NCI)
Acute Myeloid Leukemia
United States, Canada, Puerto Rico
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease StudiesRecruiting
NCT07177352Phase 3Updated Aug 21, 2026
Sponsor: Hoffmann-La Roche
Alzheimers Disease
United States, Argentina, Australia, Brazil, Canada +9 more
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of UblituximabRecruiting
NCT05877963Phase 3Updated Aug 21, 2026
Sponsor: TG Therapeutics, Inc.
Relapsing Multiple Sclerosis
United States, Poland
A Study of Brenipatide in Adult Participants With SchizophreniaRecruiting
NCT07410507Phase 2Updated Aug 21, 2026
Sponsor: Eli Lilly and Company
Schizophrenia
United States, Argentina, Brazil, China, India +2 more
A Study to Learn About The Effects of Felzartamab on Thyroid Function and Its Safety in Adults With Graves' Disease Ages 18 to 75 Years OldRecruiting
NCT07722546Phase 2Updated Aug 21, 2026
Sponsor: Biogen
Graves' Disease
United States, Puerto Rico
Testing the Effect of Teclistamab on Recurrent Plasmablastic LymphomaRecruiting
NCT07332507Phase 1Updated Aug 21, 2026
Sponsor: National Cancer Institute (NCI)
Recurrent Plasmablastic Lymphoma · Refractory Plasmablastic Lymphoma
United States
Evaluation of an Intervention for Young Adults With Diabetes: Resilient, Empowered, Active Living-Telehealth (REAL-T)Completed
NCT04023487NAUpdated Aug 21, 2026
Sponsor: University of Southern California
Diabetes Mellitus, Type 1
United States
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic MigraineRecruiting
NCT07018713Phase 3Updated Aug 21, 2026
Sponsor: Merz Therapeutics GmbH
Chronic Migraine
United States, Austria, Canada, Czechia, Denmark +8 more
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)Recruiting
NCT06841354Phase 3Updated Aug 21, 2026
Sponsor: Merck Sharp & Dohme LLC
Triple Negative Breast Neoplasms
United States, Argentina, Australia, Belgium, Brazil +29 more
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT TrialRecruiting
NCT06498635Phase 3Updated Aug 21, 2026
Sponsor: National Cancer Institute (NCI)
Lung Non-Small Cell Carcinoma · Stage II Lung Cancer AJCC v8 · Stage IIIA Lung Cancer AJCC v8 · Stage IIIB Lung Cancer AJCC v8
United States
ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to EfgartigimodRecruiting
NCT07284420Phase 2Updated Aug 21, 2026
Sponsor: argenx
AChR-Ab Seropositive Generalized Myasthenia Gravis · Myasthenia Gravis · MG · gMG
United States, Belgium, Germany, Greece, Italy +3 more
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the HeartRecruiting
NCT06935370Phase 3Updated Aug 21, 2026
Sponsor: Boehringer Ingelheim
Heart Failure
United States, Argentina, Belgium, Brazil, Bulgaria +24 more
A Research Study to Compare a New Medicine Oral Semaglutide to a Dummy Medicine in Children and Teenagers With Type 2 DiabetesCompleted
NCT04596631Phase 3Updated Aug 21, 2026
Sponsor: Novo Nordisk A/S
Diabetes Mellitus, Type 2
United States, Australia, Austria, Belgium, Czechia +17 more
Efficacy and Safety of Pegzilarginase in Patients With Arginase 1 DeficiencyCompleted
NCT03921541Phase 3Updated Aug 21, 2026
Sponsor: Immedica Pharma AB
Arginase I Deficiency · Hyperargininemia
United States, Austria, Canada, France, Germany +2 more

Previous page Next page